MANE
Veradermics, Incorporated
156.56
+7.56 (+5.07%)
52w low 32.00
152.82 high
100.0% of range
Financial Analysis
| (USD) | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.66M | 21.77M | 168.41M | 319.33M | |
| Receivables | 1.23M | 1.25M | 1.65M | 1.59M | |
| Current Assets | 18.71M | 152.49M | 397.07M | 824.75M | |
| Net PP&E | 84.00K | 125.00K | 287.00K | 989.00K | |
| Total Assets | 18.80M | 152.62M | 397.36M | 825.74M | |
| Current Liabilities | 5.69M | 9.15M | 6.72M | 11.69M | |
| Total Debt | 16.00K | 4.00K | 0.00 | 428.00K | |
| Total Liabilities | 114.81M | 273.63M | 6.72M | 12.12M | |
| Retained Earnings | -97.38M | -123.42M | -150.65M | -174.16M | |
| Shareholders Equity | -96.02M | -121.01M | 390.64M | 813.61M | |
| Working Capital | 13.02M | 143.34M | 390.35M | 813.05M | |
| Shares Outstanding | 35.08M | 37.34M | 37.34M | 41.78M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--